HilleVax acquired by XOMA Royalty for $1.95/share plus CVR; delisted from Nasdaq

HilleVax, Inc.

39,214,689 shares (77.48% of outstanding) validly tendered; minimum condition satisfied.
Shareholders receive $1.95 cash per share plus one non-transferable CVR for future payments.
CVR entitles holders to 90% of net proceeds from Legacy Assets (HIL-216, Kangh License) and net cash adjustments.
All directors and officers (CEO Hershberg, CFO Maltbie) ceased; Merger Sub directors and officers assumed roles.
Nasdaq delisting effective Sept 17, 2025; Form 15 to be filed to deregister shares.

item 2.01item 3.01item 3.03item 5.01item 5.02item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.